Continuous leg dyskinesia assessment in Parkinson's disease -clinical validity and ecological effect

Parkinsonism and Related Disorders

Volumn 26, Issue , 2016, Pages 41-46

  Ramsperger, Robert ^a   Meckler, Stefan ^a   Heger, Tanja ^b,c   van Uem, Janet ^b,c   Hucker, Svenja ^b,c   Braatz, Ulrike ^b   Graessner, Holm ^d   Berg, Daniela ^b,c   Manoli, Yiannos ^a,e   Serrano, J Artur ^f,g   Ferreira, Joaquim J ^h,i   Hobert, Markus A ^b,c   Maetzler, Walter ^b,c   Godinho, Catarina ^h   Santos, Ana T ^h   Domingos, Josefa ^h   Abreu, Daisy ^h   Larsen, Frank ^f   Fagerbakke, Øyvind ^f   Akeren, Ingvild ^f   Wangen, Hilde ^f   Maier, K S ^b   Scheck, Olga ^b   Matthews, Helen ^j   Isaacs, Tom ^j   Lewin, Alan ^j   Bresolin, Eros ^j   more..

^a Institute of Micromachining and Information Technology   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^g UNIVERSITY OF TROMSØ   (Norway)

^h INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

ⁱ INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^j Cure Parkinson's Trust   (United Kingdom)

more..

Author keywords

Ecological effect; Ecological validity; Home based assessment; Hyperkinesia; Quantitative movement assessment

Indexed keywords

LEVODOPA; ANTIPARKINSON AGENT;

AGED; ARTICLE; CLASSIFICATION ALGORITHM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; DYSKINESIA; ECOLOGICAL VALIDITY; FEMALE; HOEHN AND YAHR SCALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; UNIFIED DYSKINESIA RATING SCALE; VALIDITY; CLINICAL TRIAL; COHORT ANALYSIS; DYSKINESIA, DRUG-INDUCED; LEG; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; VIDEORECORDING;

AGED; ANTIPARKINSON AGENTS; COHORT STUDIES; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEG; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; VIDEO RECORDING;

EID: 84959538603     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2016.02.007     Document Type: Article

References (29)

1. Olanow C.W., Stern M.B., Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 2009, 72:S1-S136.
2. Fox S.H., Lang A.E. Levodopa-related motor complications-phenomenology. Mov. Disord. 2008, 23(Suppl 3):S509-S514.
3. Chung K.A., Lobb B.M., Nutt J.G., McNames J., Horak F. Objective measurement of dyskinesia in Parkinson's disease using a force plate. Mov. Disord. 2010, 25:602-608.
4. Kerr G.K., Worringham C.J., Cole M.H., Lacherez P.F., Wood J.M., Silburn P.A. Predictors of future falls in Parkinson disease. Neurology 2010, 75:116-124.
5. Wood B.H., Bilclough J.A., Bowron A., Walker R.W. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J. Neurol. Neurosurg. Psychiatry 2002, 72:721-725.
6. Fenney A., Jog M.S., Duval C. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea. Clin. Neurol. Neurosurg. 2008, 110:160-167.
7. Pietracupa S., Latorre A., Berardelli A., Fabbrini G. Parkinsonian patients and poor awareness of dyskinesias. Front. Neurol. 2014, 5:32.
8. Schaeffer E., Pilotto A., Berg D. Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease. CNS Drugs 2014, 28:1155-1184.
9. Maetzler W., Domingos J., Srulijes K., Ferreira J.J., Bloem B.R. Quantitative wearable sensors for objective assessment of Parkinson's disease. Mov. Disord. 2013, 28:1628-1637.
10. Maetzler W., Rochester L. Body-worn sensors-the brave new world of clinical measurement?. Mov. Disord. 2015, 30:1203-1205.
11. Pulliam C.L., Burack M.A., Heldman D.A., Giuffrida J.P., Mera T.O. Motion sensor dyskinesia assessment during activities of daily living. J. Park. Dis. 2014, 4:609-615.
12. Tsipouras M.G., Tzallas A.T., Rigas G., Bougia P., Fotiadis D.I., Konitsiotis S. Automated Levodopa-induced dyskinesia assessment. 2010 Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. EMBC'10 2010, 2411-2414.
13. Keijsers N.L.W., Horstink M.W.I.M., Gielen S.C. Automatic assessment of levodopa-induced dyskinesias in daily life by neural networks. Mov. Disord. 2003, 18:70-80.
14. Tsipouras M.G., Tzallas A.T., Fotiadis D.I., Konitsiotis S. On automated assessment of Levodopa-induced dyskinesia in Parkinson's disease. Proc. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. EMBS. 2011, 2679-2682.
15. Manson A.J., Brown P., O'Sullivan J.D., Asselman P., Buckwell D., Lees A.J. An ambulatory dyskinesia monitor. J. Neurol. Neurosurg. Psychiatry 2000, 68:196-201.
16. Griffiths R.I., Kotschet K., Arfon S., Xu Z.M., Johnson W., Drago J., Evans A., Kempster P., Raghav S., Horne M.K. Automated assessment of bradykinesia and dyskinesia in Parkinson's disease. J. Park. Dis. 2012, 2:47-55.
17. Horne M.K., McGregor S., Bergquist F. An objective fluctuation score for Parkinson's disease. PLoS One 2015, 10:e0124522.
18. Lopane G., Mellone S., Chiari L., Cortelli P., Calandra-Buonaura G., Contin M. Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease. Mov. Disord. 2015, 30:1267-1271.
19. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
20. Ferreira J.J., Godinho C., Santos A.T., Domingos J., Abreu D., Lobo R., Goncalves N., Barra M., Larsen F., Fagerbakke Ø., Akeren I., Wangen H., Serrano J.A., Weber P., Thoms A., Meckler S., Sollinger S., van Uem J., Maier K.S., Matthew H., Isaacs T., Duffen J., Graessner H., Maetzler W. Quantitative home-based assessment of Parkinson's symptoms: the SENSE-PARK feasibility and usability study. BMC Neurol. 2015, 15:89.
21. Goetz C.G., Tilley B.C., Shaftman S.R., Stebbins G.T., Fahn S., Martinez-Martin P., Poewe W., Sampaio C., Stern M.B., Dodel R., Dubois B., Holloway R., Jankovic J., Kulisevsky J., Lang A.E., Lees A., Leurgans S., LeWitt P.A., Nyenhuis D., Olanow C.W., Rascol O., Schrag A., Teresi J.A., van Hilten J.J., LaPelle N. Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 2008, 23:2129-2170.
22. Goetz C.G., Nutt J.G., Stebbins G.T. The unified dyskinesia rating scale: Presentation and clinimetric profile. Mov. Disord. 2008, 23:2398-2403.
23. Goetz C.G., Stebbins G.T., Chung K.A., Hauser R.A., Miyasaki J.M., Nicholas A.P., Poewe W., Seppi K., Rascol O., Stacy M.A., Nutt J.G., Tanner C.M., Urkowitz A., Jaglin J.A., Song G. Which dyskinesia scale best detects treatment response?. Mov. Disord. 2013, 28:341-346.
24. Weiss A., Sharifi S., Plotnik M., van Vugt J.P., Giladi N., Hausdorff J.M. Toward automated, at-home assessment of mobility among patients with Parkinson disease, using a body-worn accelerometer. Neurorehabil Neural Repair 2011, 25:810-818.
25. Weiss A., Brozgol M., Dorfman M., Herman T., Shema S., Giladi N., Hausdorff J.M. Does the evaluation of gait quality during daily life provide insight into fall risk? A novel approach using 3-day accelerometer recordings. Neurorehabil. Neural Repair 2013, 27:742-752.
26. Louter M., Maetzler W., Prinzen J., van Lummel R.C., Hobert M., Arends J.B.A.M., Bloem B.R., Streffer J., Berg D., Overeem S., Liepelt-Scarfone I. Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson's disease, but not high-risk individuals, from controls. J. Neurol. Neurosurg. Psychiatry 2014, 86:32-37.
27. Foreman K.B., Addison O., Kim H.S., Dibble L.E. Testing balance and fall risk in persons with Parkinson disease, an argument for ecologically valid testing. Park. Relat. Disord. 2011, 17:166-171.
28. Maetzler W., Nieuwhof F., Hasmann S.E., Bloem B.R. Emerging therapies for gait disability and balance impairment: Promises and pitfalls. Mov. Disord. 2013, 28:1576-1586.
29. Serrano J.A., Larsen F., Isaacs T., Matthews H., Duffen J., Riggare S., Capitano F., Ferreira J.J., Domingos J., Maetzler W., Graessner H. Participatory design in parkinson's research with focus on the symptomatic domains to be measured. J. Park. Dis. 2015, 15:187-196.